Jessica Y Wong1, Heath Kelly, Dennis K M Ip, Joseph T Wu, Gabriel M Leung, Benjamin J Cowling. 1. From the aSchool of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China; bVictorian Infectious Diseases Reference Laboratory, North Melbourne, Victoria, Australia; and cNational Centre for Epidemiology and Population Health, Australian National University, Canberra, Australian Capital Territory, Australia.
Abstract
BACKGROUND: During the 2009 influenza pandemic, uncertainty surrounding the seriousness of human infections with the H1N1pdm09 virus hindered appropriate public health response. One measure of seriousness is the case fatality risk, defined as the probability of mortality among people classified as cases. METHODS: We conducted a systematic review to summarize published estimates of the case fatality risk of the pandemic influenza H1N1pdm09 virus. Only studies that reported population-based estimates were included. RESULTS: We included 77 estimates of the case fatality risk from 50 published studies, about one-third of which were published within the first 9 months of the pandemic. We identified very substantial heterogeneity in published estimates, ranging from less than 1 to more than 10,000 deaths per 100,000 cases or infections. The choice of case definition in the denominator accounted for substantial heterogeneity, with the higher estimates based on laboratory-confirmed cases (point estimates = 0-13,500 per 100,000 cases) compared with symptomatic cases (point estimates = 0-1,200 per 100,000 cases) or infections (point estimates = 1-10 per 100,000 infections). Risk based on symptomatic cases increased substantially with age. CONCLUSIONS: Our review highlights the difficulty in estimating the seriousness of infection with a novel influenza virus using the case fatality risk. In addition, substantial variability in age-specific estimates complicates the interpretation of the overall case fatality risk and comparisons among populations. A consensus is needed on how to define and measure the seriousness of infection before the next pandemic.
BACKGROUND: During the 2009 influenza pandemic, uncertainty surrounding the seriousness of humaninfections with the H1N1pdm09 virus hindered appropriate public health response. One measure of seriousness is the case fatality risk, defined as the probability of mortality among people classified as cases. METHODS: We conducted a systematic review to summarize published estimates of the case fatality risk of the pandemic influenza H1N1pdm09 virus. Only studies that reported population-based estimates were included. RESULTS: We included 77 estimates of the case fatality risk from 50 published studies, about one-third of which were published within the first 9 months of the pandemic. We identified very substantial heterogeneity in published estimates, ranging from less than 1 to more than 10,000 deaths per 100,000 cases or infections. The choice of case definition in the denominator accounted for substantial heterogeneity, with the higher estimates based on laboratory-confirmed cases (point estimates = 0-13,500 per 100,000 cases) compared with symptomatic cases (point estimates = 0-1,200 per 100,000 cases) or infections (point estimates = 1-10 per 100,000 infections). Risk based on symptomatic cases increased substantially with age. CONCLUSIONS: Our review highlights the difficulty in estimating the seriousness of infection with a novel influenza virus using the case fatality risk. In addition, substantial variability in age-specific estimates complicates the interpretation of the overall case fatality risk and comparisons among populations. A consensus is needed on how to define and measure the seriousness of infection before the next pandemic.
Authors: Lincoln L H Lau; Hiroshi Nishiura; Heath Kelly; Dennis K M Ip; Gabriel M Leung; Benjamin J Cowling Journal: Epidemiology Date: 2012-07 Impact factor: 4.822
Authors: Fatimah S Dawood; A Danielle Iuliano; Carrie Reed; Martin I Meltzer; David K Shay; Po-Yung Cheng; Don Bandaranayake; Robert F Breiman; W Abdullah Brooks; Philippe Buchy; Daniel R Feikin; Karen B Fowler; Aubree Gordon; Nguyen Tran Hien; Peter Horby; Q Sue Huang; Mark A Katz; Anand Krishnan; Renu Lal; Joel M Montgomery; Kåre Mølbak; Richard Pebody; Anne M Presanis; Hugo Razuri; Anneke Steens; Yeny O Tinoco; Jacco Wallinga; Hongjie Yu; Sirenda Vong; Joseph Bresee; Marc-Alain Widdowson Journal: Lancet Infect Dis Date: 2012-06-26 Impact factor: 25.071
Authors: Fatimah S Dawood; Kirsty G Hope; David N Durrheim; Rodney Givney; Alicia M Fry; Craig B Dalton Journal: PLoS One Date: 2010-03-25 Impact factor: 3.240
Authors: Anne M Presanis; Daniela De Angelis; Angela Hagy; Carrie Reed; Steven Riley; Ben S Cooper; Lyn Finelli; Paul Biedrzycki; Marc Lipsitch Journal: PLoS Med Date: 2009-12-08 Impact factor: 11.069
Authors: Gerardo Chowell; Santiago Echevarría-Zuno; Cécile Viboud; Lone Simonsen; James Tamerius; Mark A Miller; Víctor H Borja-Aburto Journal: PLoS Med Date: 2011-05-24 Impact factor: 11.069
Authors: Christophe Fraser; Christl A Donnelly; Simon Cauchemez; William P Hanage; Maria D Van Kerkhove; T Déirdre Hollingsworth; Jamie Griffin; Rebecca F Baggaley; Helen E Jenkins; Emily J Lyons; Thibaut Jombart; Wes R Hinsley; Nicholas C Grassly; Francois Balloux; Azra C Ghani; Neil M Ferguson; Andrew Rambaut; Oliver G Pybus; Hugo Lopez-Gatell; Celia M Alpuche-Aranda; Ietza Bojorquez Chapela; Ethel Palacios Zavala; Dulce Ma Espejo Guevara; Francesco Checchi; Erika Garcia; Stephane Hugonnet; Cathy Roth Journal: Science Date: 2009-05-11 Impact factor: 47.728
Authors: Jessica Y Wong; Heath Kelly; Chung-Mei M Cheung; Eunice Y Shiu; Peng Wu; Michael Y Ni; Dennis K M Ip; Benjamin J Cowling Journal: Am J Epidemiol Date: 2015-07-18 Impact factor: 4.897
Authors: Kin On Kwok; Steven Riley; Ranawaka A P M Perera; Vivian W I Wei; Peng Wu; Lan Wei; Daniel K W Chu; Ian G Barr; J S Malik Peiris; Benjamin J Cowling Journal: BMC Infect Dis Date: 2017-05-11 Impact factor: 3.090
Authors: L Feng; J T Wu; X Liu; P Yang; T K Tsang; H Jiang; P Wu; J Yang; V J Fang; Y Qin; E H Lau; M Li; J Zheng; Z Peng; Y Xie; Q Wang; Z Li; G M Leung; G F Gao; H Yu; B J Cowling Journal: Euro Surveill Date: 2014-12-11
Authors: Stella G Muthuri; Sudhir Venkatesan; Puja R Myles; Jo Leonardi-Bee; Tarig S A Al Khuwaitir; Adbullah Al Mamun; Ashish P Anovadiya; Eduardo Azziz-Baumgartner; Clarisa Báez; Matteo Bassetti; Bojana Beovic; Barbara Bertisch; Isabelle Bonmarin; Robert Booy; Victor H Borja-Aburto; Heinz Burgmann; Bin Cao; Jordi Carratala; Justin T Denholm; Samuel R Dominguez; Pericles A D Duarte; Gal Dubnov-Raz; Marcela Echavarria; Sergio Fanella; Zhancheng Gao; Patrick Gérardin; Maddalena Giannella; Sophie Gubbels; Jethro Herberg; Anjarath L Higuera Iglesias; Peter H Hoger; Xiaoyun Hu; Quazi T Islam; Mirela F Jiménez; Amr Kandeel; Gerben Keijzers; Hossein Khalili; Marian Knight; Koichiro Kudo; Gabriela Kusznierz; Ilija Kuzman; Arthur M C Kwan; Idriss Lahlou Amine; Eduard Langenegger; Kamran B Lankarani; Yee-Sin Leo; Rita Linko; Pei Liu; Faris Madanat; Elga Mayo-Montero; Allison McGeer; Ziad Memish; Gokhan Metan; Auksė Mickiene; Dragan Mikić; Kristin G I Mohn; Ahmadreza Moradi; Pagbajabyn Nymadawa; Maria E Oliva; Mehpare Ozkan; Dhruv Parekh; Mical Paul; Fernando P Polack; Barbara A Rath; Alejandro H Rodríguez; Elena B Sarrouf; Anna C Seale; Bunyamin Sertogullarindan; Marilda M Siqueira; Joanna Skręt-Magierło; Frank Stephan; Ewa Talarek; Julian W Tang; Kelvin K W To; Antoni Torres; Selda H Törün; Dat Tran; Timothy M Uyeki; Annelies Van Zwol; Wendy Vaudry; Tjasa Vidmar; Renata T C Yokota; Paul Zarogoulidis; Jonathan S Nguyen-Van-Tam Journal: Lancet Respir Med Date: 2014-03-19 Impact factor: 30.700